Echotherapy Market Trends

  • Report ID: 5953
  • Published Date: Apr 02, 2024
  • Report Format: PDF, PPT

Echotherapy Market Trends

Growth Drivers

  • Growing Incidences of Neurological Disorders Globally - Neurological diseases including multiple sclerosis, Parkinson's, and Alzheimer's are becoming more common and causing more cases of each. The echotherapy market growth in the upcoming years is expected to be significantly impacted by this increase. On the other hand, Alzheimer's disease is becoming more common in countries where the senior population is growing. For example, in 2020, there will be about 55 million dementia patients worldwide. By 2050, there will be 139 million people on the planet, having nearly doubled every 20 years to 78 million in 2030.
  • Increasing Technological Advancements - The growth can be attributed to the growing technological advancements in echotherapy by the key manufacturers. For instance, The U.S. pivotal clinical trial to assess the safety and effectiveness of Echopulse echotherapy as a non-invasive treatment for breast fibroadenomas (BFAs) has seen the treatment of its first patients, according to Theraclion, a business that specializes in state-of-the-art medical equipment for echotherapy. Therefore, this factor is propelling the echotherapy market growth. Additionally, there is a growing amount of innovation in other medicines and high-end technologies, such as molecular imaging, drug/gene delivery, and robotic surgery, which is escalating the echotherapy market growth.
  • Growing Demand for Echotherapy - The need to treat a variety of conditions has fueled the market's rise because of rising technology and the growing need for minimally invasive therapy. Focussed ultrasound is a non-invasive therapy technique for people with thyroid nodules that may lower medical costs and enhance patient quality of life. This cutting-edge technology precisely and correctly directs ultrasonic energy beams toward targets located deep within the body without causing harm to the surrounding healthy tissue. Therefore, the demand for echotherapy as non-invasive treatment option for thyroid diseases, is propelling its echotherapy market growth.

Challenges

  • Improper Echo - Echo can occasionally reduce anxiety problems, however for other people it can also increase or cause anxiety. Alzheimer's patients may experience increased worry and distress due to an incorrect echo. The patient's mental state may be greatly affected by the echo intensity, according to the therapist. A pessimistic perspective may be shown by some echo intensity, which eventually makes one feel more depressed. This is especially difficult for those who are sad, which will hinder the market for echotherapy from expanding throughout the projected period of time.
  • Lack of Skilled Labor may Hamper the echotherapy market Growth
  • Growing price pressures of the therapy may impede the echotherapy market growth

Echotherapy Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~ 7%

Base Year Market Size (2023)

 ~ USD 1 Billion

Forecast Year Market Size (2036)

 ~ USD 3 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5953
  • Published Date: Apr 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of neurological disorders globally, increasing technological advancements, and growing demand for echotherapy are the major factors driving the growth of the echotherapy market.

The market size of echotherapy is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market are Theraclion, Royal Philips, Image-Guided Therapy, EDAP TMS, SonaCare Medical LLC, Shanghai A & S Science Technology Development Co., Ltd., ALPINION, Chongqin, Haifu Medical Technology Co., Ltd., SuperSonic Imagine, Echo Therapeutics, and others.

The prostate cancer segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample